Prevention of Cyclical Attacks of Acute Intermittent Porphyria with a Long-Acting Agonist of Luteinizing Hormone–Releasing Hormone
1984; Massachusetts Medical Society; Volume: 311; Issue: 10 Linguagem: Inglês
10.1056/nejm198409063111006
ISSN1533-4406
AutoresKarl E. Anderson, Irving M. Spitz, Shigeru Sassa, C. Wayne Bardin, Attallah Kappas,
Tópico(s)Neonatal Health and Biochemistry
ResumoTHE genetic disease acute intermittent porphyria may be exacerbated by a number of factors that are distinct from the inherited deficiency of the heme pathway enzyme, porphobilinogen deaminase (also known as uroporphyrinogen I synthase). These factors include endogenous steroid hormones and their metabolites, drugs, and nutrition.1 2 3 4 5 In some women with acute intermittent porphyria, exacerbations of symptoms occur in relation to the menstrual cycle, and in a minority, disabling premenstrual attacks occur regularly with every cycle.1 , 2 , 5 6 7 8 9 We report on a patient in whom premenstrual exacerbations of acute intermittent porphyria, which had previously occurred every month for at least two years, were . . .
Referência(s)